Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

Authors :: Wilpe, S. van
Simnica, Donjete
Slootbeek, P. H.J.
Ee, T.J. van
Pamidimarri Naga, S.
Gorris, M.A.J.
Woude, L.L. van der
Sultan, S.
Koornstra, R.H.
Oort, I.M. van
Gerritsen, W.R.
Kroeze, L.
Simons, M.
Vries, I.J.M. de
Mehra, N.
Wilpe, S. van
Simnica, Donjete
Slootbeek, P. H.J.
Ee, T.J. van
Pamidimarri Naga, S.
Gorris, M.A.J.
Woude, L.L. van der
Sultan, S.
Koornstra, R.H.
Oort, I.M. van
Gerritsen, W.R.
Kroeze, L.
Simons, M.
Vries, I.J.M. de
Mehra, N.
Source :: Oncoimmunology; 2162-4011; 1; 11; 2094133; ~Oncoimmunology~~~~~2162-4011~1~11~~2094133
Publication Year :: 2022
Abstract: Contains fulltext : 252002.pdf (Publisher’s version ) (Open Access)

Database :: OAIster
Journal :: Oncoimmunology; 2162-4011; 1; 11; 2094133; ~Oncoimmunology~~~~~2162-4011~1~11~~2094133
Publication Type :: Electronic Resource
Accession number :: edsoai.on1367101480
Document Type :: Electronic Resource

Tools